MedPath

华润三九(唐山)药业有限公司

Ownership
-
Established
1996-03-28
Employees
-
Market Cap
-
Website
http://haowawa.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

104

NMPA:104

Drug Approvals

Ibuprofen Arginine

Product Name
精氨酸布洛芬
Approval Number
国药准字H20070135
Approval Date
Feb 21, 2024
NMPA

Ibuprofen Arginine Powder

Product Name
精氨酸布洛芬散
Approval Number
国药准字H20080400
Approval Date
Jan 29, 2023
NMPA

Junior Vitamin Granules

Product Name
小儿维生素颗粒
Approval Number
国药准字H20080392
Approval Date
Jan 29, 2023
NMPA

Ibuprofen Arginine Granules

Product Name
精氨酸布洛芬颗粒
Approval Number
国药准字H20070139
Approval Date
Jul 19, 2021
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20065542
Approval Date
Apr 28, 2021
NMPA

Montmorillonite Granules

Product Name
畅言停
Approval Number
国药准字H20061168
Approval Date
Apr 28, 2021
NMPA

Ambroxol Hydrochloride Oral Solution

Product Name
盐酸氨溴索口服溶液
Approval Number
国药准字H20065543
Approval Date
Apr 28, 2021
NMPA

独一味颗粒

Approval Number
国药准字Z20090343
Approval Date
Feb 4, 2021
NMPA

独一味咀嚼片

Approval Number
国药准字Z20080583
Approval Date
Feb 4, 2021
NMPA

Iron Dextran Granules

Product Name
右旋糖酐铁颗粒
Approval Number
国药准字H20100072
Approval Date
Feb 4, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 11
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.